Biofinancing values have tailed off a bit after a strong start to 2026, but March has seen $50m+ rounds for R1, Crossbow, Excalipoint, and Prolium.

ACIP is being broken up. No it’s not. On Thursday afternoon, an outspoken member of the CDC’s Advisory Committee on Immunization Practices claimed that the

In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a

The US FDA has approved a fourth product via its new National Priority Voucher Programme — a 7.2 mg dose of Novo Nordisk’s weight loss

The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to